Skip to content
Cyclodextrin News

Cyclodextrin News

A forum for researchers, students and applicants in the field of cyclodextrin technology

  • Home
  • Pharma applications
  • Non-pharma applications
  • CD derivatives
  • Events
  • E-ducation
  • Ask Questions

Tag: Clinical trial

January 14, 2021 Drug delivery / Pharma applications

Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of SBECD-enabled Ganaxolone in CDKL5 Deficiency Disorder (CDD)

Marinus Pharmaceuticals, Inc. (Nasdaq: MRNS), a pharmaceutical company dedicated to the development of innovative therapeutics to treat rare seizure disorders,

Continue reading

January 8, 2021 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Announces Positive Efficacy Data in Patients with Niemann-Pick Disease Type C

Home-based intravenous infusions of Trappsol® Cyclo™ for up to one year show improvement in disease features or disease stabilization Cyclo

Continue reading

December 11, 2020 Drug delivery / Pharma applications

Top-line final data from CD-enabled Cantrixil Phase I study confirms prior positive efficacy and safety signals

Kazia Therapeutics Limited, an Australian oncology-focused biotechnology company shared top-line final data from its phase I study of Cantrixil (TRX-E-002-1)

Continue reading

November 12, 2020 CD as API / Pharma applications

Cholesterol chelator, HPβCD for renal diseases

There is increasing evidence that accumulation of intracellular lipids in the kidney contributes to the pathogenesis and progression of kidney

Continue reading

October 29, 2020 Drug delivery / Pharma applications

Lilly’s baricitinib/remdesivir combo lowers recovery time in hospitalised COVID-19 patients

Eli Lilly has unveiled promising new data from a study investigating the efficacy of baricitinib when combined with with Gilead’s

Continue reading

October 20, 2020 Drug delivery / Pharma applications

Results of HPBCD-enabled MTX110 Phase I Study

Midatech Pharma PLC, an R&D biotechnology company focused on improving the bio‐delivery and biodistribution of medicines, announced encouraging headline results

Continue reading

October 19, 2020 CD as API / CD derivatives / Pharma applications

Cyclo Therapeutics Phase 3 Pivotal Program Can Begin Enrollment Per US FDA

Cyclo Therapeutics will now proceed in the US with its Phase 3 clinical trial of Trappsol® Cyclo™ for treatment of Niemann-Pick

Continue reading

October 11, 2020 Drug delivery / Pharma applications

Final Results of NIAID’s Trial Expand Clinical Benefits of Veklury® (remdesivir) for the Treatment of COVID-19

— Final Day 29 Data Show Superior Efficacy of Veklury Compared with Placebo in Hospitalized Patients Receiving Standard of Care

Continue reading

October 9, 2020 Drug delivery / Pharma applications

Ivermectin against COVID-19

Ivermectin is a medication used to treat a number of parasite infections. Chemically, this compound and derivatives are macrocyclic lactones

Continue reading

September 25, 2020 Drug delivery / Pharma applications

Novel dexamethasone formulation shows efficacy and safety with once-daily use

Eric D. Donnenfeld, a consultant to Oculis reported for Ophthalmology Times on the results of a phase 2 trial: dexamethasone

Continue reading

Posts navigation

1 2 3 … 6 Next Posts»

Recent Posts

  • β-cyclodextrin and ion-doped polypyrrole composite nanomaterials as electrodes for seawater desalination
  • Roquette on the role of cyclodextrins in vaccines
  • CD-based Nanoparticles from CNR-ISMN Institute of Nanostructured Materials
  • Marinus Pharmaceuticals Receives Positive Response from FDA on Sufficiency of One Phase 3 Clinical Trial for Filing of New Drug Application (NDA) for the Use of SBECD-enabled Ganaxolone in CDKL5 Deficiency Disorder (CDD)
  • Changes in the management of CycloLab

Tags

antiviral Betadex Sulfobutyl Ether Sodium Biotechnology Cancer therapy Captisol Cholesterol Clinical trial conference coronavirus Covid-19 cyclodextrin polymer Dexolve drug delivery drug delivery systems Drugs FDA Food Gilead History HPBCD Nanoparticles nanotechnology Niemann Pick Disease Polymer RAMEB remdesivir SBECD Special issue Synthesis

Follow Us

  • LinkedIn
  • Twitter
  • Facebook

Categories

  • Agriculture (7)
  • Analysis (12)
  • CD as API (93)
  • CD derivatives (117)
  • Cosmetics and toilettry (10)
  • Drug delivery (181)
  • E-ducation (40)
  • Environmental (38)
  • Events (91)
  • Food (53)
  • Gene delivery (6)
  • In Hungarian (4)
  • Non-pharma applications (91)
  • Other industrial use (33)
  • Pharma applications (333)
  • Supramolecular systems (7)
  • Uncategorized (21)

Top Posts

  • Roquette on the role of cyclodextrins in vaccines
  • β-cyclodextrin and ion-doped polypyrrole composite nanomaterials as electrodes for seawater desalination
  • Changes in the management of CycloLab
  • Special Issue "Pharmaceutical and Biomedical Applications of Cyclodextrins and Derivatives"
  • How air fresheners work?
  • Cyclolab and EpiPharma Form Joint Venture company Targetrin Therapeutics to Develop and Commercialize novel conjugated Cyclodextrin – Peptide drugs
  • Nitric oxide in the treatment of coronavirus disease (COVID-19)
  • Use of sulfobutylether beta cyclodextrin for preparing ceramics
  • Remdesivir dry powder inhalation formulation, pharmacokinetic study in hamsters
  • Cyclo Therapeutics Announces Positive Efficacy Data in Patients with Niemann-Pick Disease Type C

Subscribe to Blog via Email

Enter your email address to subscribe to this blog and receive notifications of new posts by email.

Join 278 other subscribers